On August 19, 2009, Baeyens-Cabrera, Jose Manuel; Buschmann, Helmut H.; Vela Hernandez, Jose Miguel; Zamanillo-Castanedo, Daniel; Nieto-Lopez, Francisco Rafael published a patent.Quality Control of 3-Amino-7-(diethylamino)-5-phenylphenazin-5-ium chloride The title of the patent was Use of compounds binding to the sigma receptor for the treatment of neuropathic pain developing as a consequence of chemotherapy. And the patent contained the following:
The invention discloses the use of compounds binding to the sigma receptor for the treatment or prevention of neuropathic pain resulting from chemotherapy. The experimental process involved the reaction of 3-Amino-7-(diethylamino)-5-phenylphenazin-5-ium chloride(cas: 4569-86-2).Quality Control of 3-Amino-7-(diethylamino)-5-phenylphenazin-5-ium chloride
The Article related to chemotherapy neuropathic pain treatment sigma receptor ligand analgesic, Pharmacology: Effects Of Nervous System- and Behavior-Affecting Drugs and Neuromuscular Agents and other aspects.Quality Control of 3-Amino-7-(diethylamino)-5-phenylphenazin-5-ium chloride
Referemce:
Chloride – Wikipedia,
Chlorides – an overview | ScienceDirect Topics